Man in lab with beaker

Our Therapies

Our inventive approach combines innovative technology with new perspectives on traditional therapy to deliver breakthrough treatments—because patients deserve better options.

Products

Products

JELMYTO (mitomycin) for pyelocalyceal solution
Our first FDA-approved therapy using our novel RTGel™ technology, JELMYTO is the first and only treatment of its kind and received breakthrough approval in April 2020.
Instructions for: Pharmacy  |  Administration

Urologic solutions intended for use with our products
Chilling Block

The UroGen Pharma Chilling Block supports temperature-controlled chilling with chambers appropriately sized for the vials and syringes needed to prepare JELMYTO.

UroJect12 Syringe Lever

A multiuse device, the UroJect12 Syringe Lever enables ease of instillation. JELMYTO is viscous, even when chilled, and must be instilled with the UroJect12 device.

Ordering

The Chilling Block and UroJect12 Syringe Lever are available at no cost to requesting licensed US physicians and licensed US institutions. Limit 1 per customer. Other terms and conditions apply and may be subject to change at any time within the discretion of UroGen Pharma. To request a Chilling Block or UroJect12 Syringe Lever, submit your information to supplies@urogen.com.

UroGen's provision of the Chilling Block and UroJect12 Syringe Lever at no cost to requesting licensed US physicians and licensed US institutions is not conditioned on any use, prescription, purchase, or recommendation of JELMYTO (or any other UroGen Pharma product).